ADX71743
== ADX71743 ==
ADX71743 is a pharmacological compound that acts as a selective positive allosteric modulator of the metabotropic glutamate receptor 7 (mGluR7). It has been studied for its potential therapeutic effects in various neurological disorders.
Mechanism of Action[edit]
ADX71743 functions by binding to the allosteric site of the mGluR7 receptor, enhancing its response to the neurotransmitter glutamate. This modulation can influence synaptic transmission and neuroplasticity, which are critical processes in the central nervous system.
Therapeutic Potential[edit]
Research has indicated that ADX71743 may have potential applications in the treatment of anxiety disorders, depression, and epilepsy. By modulating mGluR7 activity, it may help to restore normal neurotransmitter balance and alleviate symptoms associated with these conditions.
Pharmacokinetics[edit]
The pharmacokinetic profile of ADX71743 includes its absorption, distribution, metabolism, and excretion. Detailed studies are required to fully understand its bioavailability and half-life in the human body.
Research and Development[edit]
ADX71743 is currently under investigation in preclinical and clinical trials. Its efficacy and safety profile are being evaluated to determine its potential as a therapeutic agent.
Related Compounds[edit]
Other compounds that act on metabotropic glutamate receptors include LY354740, MPEP, and PHCCC. These compounds have varying effects on different subtypes of mGluRs and are also being studied for their therapeutic potential.
See Also[edit]
- Metabotropic glutamate receptor
- Allosteric modulator
- Neurotransmitter
- Synaptic transmission
- Neuroplasticity
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
